链接：https://www.abinscience.cn/product/68/14511.html

名称：Anti-HeV/NiV Glycoprotein G Antibody (HENV-26)

货号：VK685033

种属反应性：Hendra virus (isolate Horse/Autralia/Hendra/1994) & Nipah virus

宿主：Mouse

形式：Liquid

纯度：>95% as determined by SDS-PAGE.

克隆性：Monoclonal

同种型：IgG1, kappa

应用：ELISA, FCM, Neutralization

Accession号 O89343, Q9IH62

靶点：G, Glycoprotein G, Attachment glycoprotein, Receptor binding protein, RBP

用途范围：仅用于科研

储存：Use  a manual defrost freezer and avoid repeated freeze-thaw cycles. Store  at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C  long term.

产品介绍：Anti-HeV/NiV  Glycoprotein G Antibody (HENV-26)  是abinScience推出的高特异性小鼠单克隆抗体，靶向亨德拉病毒（HeV）和尼帕病毒（NiV）的G糖蛋白。该抗体经ELISA、流式细胞术（FCM）及中和实验多重验证，具有>95%的高纯度，适用于新发病原体研究、疫苗开发及抗病毒药物筛选等领域。其卓越的亲和力与稳定性为病毒侵入机制研究提供可靠工具，尤其适用于高生物安全等级（BSL-4）相关基础与转化研究。abinScience产品具有亲和力高，灵敏度高，特异性好，稳定性强等优势。

产品购买联系方式：027-87433958/17302791434

邮箱：info@abinscience.com

参考文献：

1、Architecture and antigenicity of the Nipah virus attachment glycoprotein. PMID: 35239409/

2、Structural insights into the Langya virus attachment glycoprotein. PMID: 38815575

3、Investigating  small molecules in propolis as Nipah virus glycoprotein (NiV-G)  inhibitors through molecular interaction studies. PMID: 40051842/

4、Therapeutic  administration of a cross-reactive mAb targeting the fusion  glycoprotein of Nipah virus protects nonhuman primates. PMID: 38569014

5、Structure and design of Langya virus glycoprotein antigens. PMID: Update in:/An  attachment glycoprotein nanoparticle elicits broadly neutralizing  antibodies and protects against lethal Nipah virus infection. PMID:  39217188

6、A  highly effective ferritin-based divalent nanoparticle vaccine shields  Syrian hamsters against lethal Nipah virus. PMID: 38911870/

7、Evidence  of a potential receptor-binding site on the Nipah virus G protein  (NiV-G): identification of globular head residues with a role in fusion  promotion and their localization on an NiV-G structural model. PMID:  16840334

8、A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts protection from disease. PMID: 39240113/

9、Establishing an immune correlate of protection for Nipah virus in nonhuman primates. PMID: 39702562

10、Nipah  virus attachment glycoprotein ectodomain delivered by type 5 adenovirus  vector elicits broad immune response against NiV and HeV. PMID:  37577376/

11、In  silico identification of potential drug-like molecules against G  glycoprotein of Nipah virus by molecular docking, DFT studies, and  molecular dynamic simulation. PMID: 36036362

12、Ferritin  nanoparticle-based Nipah virus glycoprotein vaccines elicit potent  protective immune responses in mice and hamsters. PMID: 39293542/

13、A  Soluble Version of Nipah Virus Glycoprotein G Delivered by Vaccinia  Virus MVA Activates Specific CD8 and CD4 T Cells in Mice. PMID: 31878180

14、A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge. PMID: 22875827/

15、Structural biology of Nipah virus G and F glycoproteins: Insights into therapeutic and vaccine development. PMID: 40261700

16、Identification of the cell binding domain in Nipah virus G glycoprotein using a phage display system. PMID: 28082163/

17、Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine. PMID: 34956199

18、A  Recombinant Chimeric Cedar Virus-Based Surrogate Neutralization Assay  Platform for Pathogenic Henipaviruses. PMID: 37243163/

19、Epitope-Based Peptide Vaccine against Glycoprotein G of Nipah Henipavirus Using Immunoinformatics Approaches. PMID: 32377531

20、Distinct  VSV-based Nipah virus vaccines expressing either glycoprotein G or  fusion protein F provide homologous and heterologous protection in a  nonhuman primate model. PMID: 36508878

21、Cysteines  in the stalk of the nipah virus G glycoprotein are located in a  distinct subdomain critical for fusion activation. PMID: 22496210/

22、Rhabdovirus-based vaccine platforms against henipaviruses. PMID: 25320306

24、Cell-Free Expression of Nipah Virus Transmembrane Proteins for Proteoliposome Vaccine Design. PMID: 40458951

详情请咨询 abinScience 亚洲区官方子公司 —— 武汉艾必赛生物技术有限公司

武汉艾必赛生物技术有限公司成立于 2023 年，是 abinScience 在亚洲地区设立的官方全资子公司，全面负责 abinScience 品牌在亚太市场的科研试剂推广、销售及技术支持工作。

依托严格的产品研发体系和国际化的质量管理标准，武汉艾必赛与 AtaGenix、ProteoGenix 等知名品牌保持长期战略合作，现已构建起涵盖抗体、重组蛋白、工具酶、试剂盒、实验耗材在内的多品类供应体系，面向区域内科研机构、高校实验室与生物医药企业，提供稳定、高效、可信赖的产品与服务。

核心业务覆盖：
✅ 抗体产品（单抗、多抗、重组抗体等）
✅ 蛋白与多肽试剂（标签蛋白、功能蛋白等）
✅ 分子与细胞实验相关耗材
✅ 定制化研发服务（蛋白表达、抗体定制、亲和力成熟等）
✅ 科研供应链整合与项目配套支持

武汉艾必赛始终秉持“Empowering Bioscience Discovery”的理念，为亚太地区的生命科学研究持续注入高质量动能。